AG

AGE1 — Pre-Seed & Seed VC Firm

VC
Profile updated October 2026Website

AGE1 is a Pre-Seed, Seed venture capital firm investing in Healthcare, AI / ML, Consumer. The firm has 27 portfolio companies in our records.

Portfolio
27 companies on record
Partners
3 listed
Stage
Pre-Seed, Seed
Sectors
Healthcare, AI / ML, Consumer
Check size
Not in our records
AUM
Not in our records

Last verified: 2026-10-28

How to approach: cold outreach ok
Stage

Pre-Seed, Seed

Portfolio

27+ companies

Team

3 partners

Investment Thesis

An earliest-stage longevity biotech solo-GP fund backing contrarian founders building therapeutics and tools to extend healthy lifespan and treat age-related disease. It is highly specialized but more biotech-heavy than consumer-facing.

How AGE1 invests

AGE1 is a vc firm. The firm invests at the Pre-Seed, Seed stages, with a focus on Healthcare, AI / ML, Consumer.

Our records include 1 fund raised by the firm.

AGE1 has backed 27 companies in our records, including Conception Bio, Loyal, NewLimit.

Partners & Team

AC

Alex Colville

General Partner

SG

Solo GP

GP

Longevity
Biotech
Pre-seed
LC

Lily Clayton

Director of Operations

Industry Focus

Invests In

Healthcare
AI / ML
Consumer

Funds

AGE1 Fund I

2020
investing

Recent Activity

Raised AGE1 Fund I

2020 · fund records

Portfolio Companies (27)

Other

CO

Conception Bio

Turning stem cells into human eggs to reimagine family planning

LO

Loyal

Healthspan and lifespan extension for dogs

NE

NewLimit

Reprogramming the epigenome to add healthy years to human life

PR

Precision Bioscience

EXITED: IPO

Novel gene editing technology to develop new class of medicines

RE

Reservoir Neuroscience

Therapeutics to heal the blood-brain barrier

SK

Skeletalis

Targeted therapies for bone regeneration to treat age-related bone loss

ST

Stealth

Developing the first human aging drugs

GE

General Control

Multiplex-editing therapies to target age-related disease

UN

Until Labs

Cryopreservation technology for tissues and organs to end organ supply shortages

BE

Bexorg

Biotechnology / neuroscience tools·Not clearly stated

Neuroscience and drug discovery company focused on human brain preservation and research models.

How to pitch AGE1
  • •Raising at Pre-Seed, Seed? You're squarely in their sweet spot.
  • •Lead with your fit in Healthcare, AI / ML, Consumer — the sectors they actively back.
  • •cold outreach ok
  • •Address your outreach to a specific partner, such as Alex Colville, General Partner.
  • •A warm introduction beats a cold email. Get matched and request an intro.

Featured In

Browse More Investors

Fundraising resources

Frequently Asked Questions

See if AGE1 is a match for your startup

Upload your pitch deck to see how well you match with AGE1 and 10,000+ other investors.

Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT

Is this your profile? Request a correction or removal